Issued to
Ingrid Bakken
Want to report a typo or a mistake?
Credential Verification
Issue date: March 20, 2025
ID: 0c8cac2e-9246-459e-8f1b-8833686da09c
Issued by
Mycology Research Laboratories
Type
Webinar
Level
Professional
Format
Online
Duration
45 minutes
Price
Free
Description
Children with mild to borderline intellectual disabilities (MBID) have problems with adaptive functioning in social situations and in peer relations. They are less accepted or even rejected by peers and have problems building social relations (Freeman, 2000, Gresham and MacMillan, 1997, Gresham et al., 1996, Guralnick, 1997, Hall et al., 2005, Maughan et al., 1999). Autistic Spectrum Disorder (ASD) includes a heterogeneous group of complex neurodevelopment disorders (dyslexia, ADHD and dyscalculia) which are associated with disturbed redox homeostasis. These neurodevelopment disorders are due to an interplay of factors affecting certain neural circuits, oxidative stress, reactive oxygen species, neuroinflammation and mitochondrial dysfunction (80%). This 45 minute lecture will outline how mushroom nutrition in the form of Hericium erinaceus biomass (Hericium-MRL) can address the symptoms associated within this heterogeneous group of complex neurodevelopment conditions by addressing: -high reactive oxygen species (ROS) -neuroinflammation -mitochondrial dysfunction -oxidative stress
Skills
Symptoms that characterise complex neurodevelopment disorders (ASD, dyslexia, ADHD and dyscalculia)
Signs of disturbed redox homeostasis
Importance of addressing high reactive oxygen species (ROS), neuroinflammation, mitochondrial dysfunction and oxidative stress in MBID clients.
How mushroom nutrition increases Lipoxin A4 (LAX4) and the importance with respect to reducing neuroinflammation and inflammation.
How mushroom nutrition provides a high concentration of superoxide dismutase (SOD) which addresses high ROS levels f) How mushrooms nutrition disrupts inflammation caused by NLRP3 inflammasome components.
Importance of electropharmacogram profiling in MBID diagnosis and tracking changes in profiling in 90 days.